Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

Go back to Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
(NASDAQ: SEER) Delayed: 1.76 --0 (-0%)
Previous Close $1.76    52 Week High
Open $1.76    52 Week Low
Day High $1.76    P/E N/A 
Day Low $1.76    EPS
Volume 10       

(NASDAQ: SEER) Delayed: 1.76 --0 (-0%)
Previous Close $1.76    52 Week High
Open $1.76    52 Week Low
Day High $1.76    P/E N/A 
Day Low $1.76    EPS
Volume 10